US 11214574
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted A61PA61P35/00
Quick answer
US patent 11214574 (Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)) held by Prelude Therapeutics, Incorporated expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prelude Therapeutics, Incorporated
- Grant date
- Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P35/00